StockData

Zhengye Biotechnology Holding Ltd (ZYBT) stock

ZYBTNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$1.52+0.09 (+6.29%)

Close on Nov 17, 2026Market cap $72.03MP/E –Yield –

Zhengye Biotechnology EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2024 it was 0.25 CNY, down 63.8% from the year before.

Annual eps

PeriodPeriod endValueChange
FY2024Dec 31, 20240.25 CNY-63.8%
FY2023Dec 31, 20230.69 CNY-32.4%
FY2022Dec 31, 20221.02 CNY–

More Zhengye Biotechnology figures

See a number that looks wrong?